Sort
25,944 grants matching “neurodegeneration”
CAA, Tau and Neurodegeneration
$197,111Cristian Lasagna-Reeves · Indiana University Indianapolis · RF1 · FY2024 · AG
Immunogenetic contribution to the progression of preclinical Alzheimer's disease
$197,023Hyun-Sik Yang · Brigham And Women'S Hospital · K23 · FY2019 · AG
Neurodegeneration by reactivation of cell cycle in neurons
$196,988Hyoung-Gon Lee · Case Western Reserve University · R21 · FY2007 · AG
Glucocerebrosidase mutations in a mouse synucleinopathy model
$196,988Robert L Nussbaum · University Of California, San Francisco · R33 · FY2011 · AG
OGT Overexpression in Women with Lupus
$196,966Bruce C. Richardson · University Of Michigan At Ann Arbor · R21 · FY2008 · AR
Measuring and manipulating stress-responsive neuronal activity to improve post-stroke outcomes
$196,960Morgan Stuart Bridi · West Virginia University · P20 · FY2022 · GM
Analysis of cellular factors limiting productive JC virus infections
$196,927James M Pipas · University Of Pittsburgh At Pittsburgh · R21 · FY2022 · AI
TPA MEDIATED NEURODEGENERATION AND MICROGLIA ACTIVATION
$196,917State University New York Stony Brook · R01 · FY2000 · NS
T cell/astrocyte fusions as a novel form of trained immunity to infection
$196,912E. Ashley Moseman · Duke University · R21 · FY2024 · NS
Functional Validation of Parkinsons Disease Susceptibility Genes in Drosophila
$196,875Joshua M Shulman · Baylor College Of Medicine · R21 · FY2014 · NS
Cell-type specific cyclophilin D gene silencing in the brain
$196,875Tibor Kristian · University Of Maryland Baltimore · R21 · FY2008 · NS
Astrocyte-neuron regulation of autophagy and lysosomal pathways in proteotoxic stress associated with alpha-synucleinopathies
$196,875Sandra L. Maday · University Of Pennsylvania · R21 · FY2025 · AG
Characterization of Orexin/Hypocretin Kinetics in Alzheimer's Disease
$196,875Brendan Patrick Lucey · Washington University · R21 · FY2022 · AG
UBIQUITIN DEFICIENCY IN AGING AND NEURODEGENERATION
$196,800Stanford University · R21 · FY2005 · AG
Immunogenetic contribution to the progression of preclinical Alzheimer's disease
$196,775Hyun-Sik Yang · Brigham And Women'S Hospital · K23 · FY2021 · AG
MURINE MODELS OF FRONTOTEMPORAL DEMENTIA
$196,757Robert V Farese · University Of California, San Francisco · P50 · FY2011 · AG
Identification of intrinsic and extrinsic regulators of TDP43 splicing function
$196,750Rajat Rohatgi · Stanford University · R21 · FY2022 · AG
Impact of actin binding protein Coronin 1C in the pathogenesis of Parkinson's disease
$196,750Birgitt Schuele · Stanford University · R21 · FY2023 · NS
Quantitative Social Phenotyping in Alzheimer's Disease
$196,723Joel Armando Salinas · Massachusetts General Hospital · K23 · FY2020 · AG
Quantitative Social Phenotyping in Alzheimer's Disease
$196,723Joel Armando Salinas · Massachusetts General Hospital · K23 · FY2019 · AG
Developing UPR Modulators as Novel Therapeutics for Neurodegeneration
$196,688Bradley J Backes · Metafold Therapeutics, Inc. · R41 · FY2011 · NS
Neuropathology and Optical Imaging Core
$196,635Howard Brent Clark · University Of Florida · P01 · FY2011 · NS
Glial-neuronal interactions underlying the molecular feedback between HIV viral p
$196,575Sulie Lin Chang · Seton Hall University · R21 · FY2013 · DA
Biomarkers of Inflammation, Neurodegeneration and Age-Associated Cognitive Impairment
$196,485Alison Ruth Weiss · Oregon Health & Science University · K01 · FY2022 · AG
Vector-based models of substantia nigra degeneration
$196,459Ronald L Klein · Louisiana State Univ Hsc Shreveport · R01 · FY2006 · NS